D. E. Shaw & Co., Inc. Rhythm Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 10,462 shares of RYTM stock, worth $426,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,462

Previous 128,492 91.86%

Holding current value

$426,954

Previous $5.91 Million 92.33%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$39.12 - $52.44 $4.62 Million - $6.19 Million	-118,030 Reduced 91.86%	10,462 $453,000
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $2.75 Million - $6.38 Million	128,492 New	128,492 $5.91 Million
Q1 2023 May 15, 2023	SELL	$16.88 - $34.24 $1.31 Million - $2.65 Million	-77,327 Reduced 21.75%	278,203 $4.96 Million
Q4 2022 Feb 14, 2023	BUY	$22.25 - $30.25 $3.84 Million - $5.22 Million	172,461 Added 94.21%	355,530 $10.4 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $630,281 - $4.52 Million	146,577 Added 401.67%	183,069 $4.49 Million

Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $188,738 - $741,039	-60,493 Reduced 62.37%	36,492 $151,000
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $594,518 - $1.19 Million	96,985 New	96,985 $1.12 Million
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $586,213 - $713,775	-31,653 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $640,973 - $1.25 Million	31,653 New	31,653 $673,000
Q1 2019 May 15, 2019	SELL	$24.76 - $31.66 $271,914 - $347,690	-10,982 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$24.11 - $31.34 $992,825 - $1.29 Million	-41,179 Reduced 78.95%	10,982 $295,000
Q3 2018 Nov 14, 2018	BUY	$26.99 - $35.85 $393,676 - $522,908	14,586 Added 38.82%	52,161 $1.52 Million
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $639,526 - $1.32 Million	37,575 New	37,575 $1.18 Million

Others Institutions Holding RYTM

# of Institutions

176

Shares Held

62.4M

Call Options Held

880K

Put Options Held

84.1K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.27B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account